An observational study in Sex, Age and Gastric Cancer, sponsored by Seoul National University Bundang Hospital. Completed. Per ClinicalTrials.gov, last updated 2023-04-13.
Sponsored by Seoul National University Bundang Hospital · Observational
Gastric cancer (GC) is more prevalent in males than in females. One of these differences could be the effect of sex hormones such as estrogens. However, few reports have been reported regarding sex and age differences of incidence and survival of GC. The aim of this study was to evaluate the effect of sex and age on the incidence and survival of GC. And we would like to further analyze single GC and synchronous multiple GC, EBV, etc.
2,851 studies on the registry are indexed under Stomach Neoplasms; 864 are open to participants now.
This study's enrollment of 14,900 is above the median of 274 across 670 observational studies indexed under Stomach Neoplasms.
Browse Stomach Neoplasms studies →Seoul National University Bundang Hospital is the lead sponsor of 368 studies on the registry; 55 are open to participants now.
Counted across the registry records on this site, refreshed daily.
patients diagnosed with Gastric cancer at the Seoul National University Bundang Hospital were analyzed retrospectively from May 2003 to February 2020. The data were collected using clinical data warehouses (CDW), and electronic medical records (EMR) were reviewed as needed.
exclusion criteria:
Evaluate the effect of sex and age on the incidence and survival of GC.
Survival rate
Survival rate of gastric cancer on sex and age
Time frame: up to 120 months
histologic type
histologic type of gastric cancer on sex and age
Time frame: about 18 years
No study locations are listed for this record.
This study is completed, as verified in Apr 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Seoul National University Bundang Hospital